Career history of Robert L. Kirkman
Former positions of Robert L. Kirkman
Companies | Position | Start | End |
---|---|---|---|
ONCORUS, INC. | Director/Board Member | 2019-07-31 | 2021-06-15 |
Independent Dir/Board Member | 2019-07-31 | 2021-06-15 | |
TRILLIUM THERAPEUTICS | Director/Board Member | 2013-12-16 | 2019-04-28 |
Chairman | 2019-04-28 | 2021-04-27 | |
Independent Dir/Board Member | 2013-12-16 | 2021-04-27 | |
CASCADIAN THERAPEUTICS INC (USA) | Director/Board Member | 2011-07-07 | 2016-01-10 |
Chief Executive Officer | 2007-10-06 | 2016-01-10 | |
President | 2007-10-06 | 2016-01-10 | |
PARKWAY B | Director of Finance/CFO | 2008-07-14 | 2008-07-14 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | President | 2005-12-31 | 2007-12-10 |
Xcyte Therapies, Inc. | Chief Executive Officer | 2004-12-31 | 2006-03-29 |
Corporate Officer/Principal | 2003-12-31 | 2004-12-31 | |
President | 2004-12-31 | 2006-03-29 | |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Public Communications Contact | 1997-12-31 | 2002-12-31 |
Training of Robert L. Kirkman
Yale University | Undergraduate Degree |
Harvard Medical School | Doctorate Degree |
Statistics
International
United States | 8 |
Canada | 3 |
Operational
President | 3 |
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Sectoral
Health Technology | 6 |
Consumer Services | 3 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ONCORUS, INC. | Health Technology |
Private companies | 6 |
---|---|
Xcyte Therapies, Inc. | Health Technology |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | Health Services |
Cascadian Therapeutics LLC
Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC was a clinical-stage biopharmaceutical company, which focused on the development of therapeutic products for the treatment of cancer. Its product ONT-380, was an orally active and selective small-molecule HER2 inhibitor. The firm also developed preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on August 23, 1985 and was headquartered in Bothell, WA. | Health Technology |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Health Technology |
Parkway Bank (Lenoir, North Carolina)
Parkway Bank (Lenoir, North Carolina) Regional BanksFinance Parkway Bank engages in the provision of commercial banking services. It offers checking and savings accounts, mortgage lending, and deposits. The company was founded on August 9, 2001 and is headquartered in Lenoir, NC. | Finance |
Trillium Therapeutics ULC
Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Robert L. Kirkman
- Experience